Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain-Body combo training tested for stroke and moyamoya recovery

NCT ID NCT07144930

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 28, 2026 · Updated 2 times

Summary

This study explores whether a training program that mixes cognitive tasks (like memory and attention exercises) with physical therapy can improve recovery in people with post-stroke cognitive impairment or Moyamoya disease. Researchers will also use brain imaging to see how thinking and movement are linked. The trial involves 210 participants and compares the combined training to motor training alone over 4 weeks, with follow-ups up to a year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cognitive-motor incorporated training (MCIT) program
What this could lead to
If successful, this could point toward a more effective rehabilitation approach for people with stroke or Moyamoya disease, potentially improving both thinking and movement.
What could go wrong
This is an early-stage study with a small number of participants. The training is short (4 weeks), and results may not apply to all patients. There is no guarantee the combined training will outperform standard motor training alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 210 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 100 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Part 1: Inclusion Criteria: * For aged-matched healthy controls: 1. being 20 years of age or older 2. the ability to stand for more than 30 seconds 3. a MoCA score of higher than 26. * For PSCI participants: 1. Diagnosis of stroke confirmed by brain CT or MRI, with symptom onset more than 7 days prior (subacute or chronic phase) 2. Being 20 years of age or older 3. The ability to stand for more than 30 seconds 4. a MoCA score of less than 26 * For the MMD group: 1. a confirmed diagnosis of Moyamoya disease or Moyamoya syndrome through CT scan or angiography 2. If stroke occurred, being in the subacute phase (one week post-stroke) 3. being 20 years of age or older 4. the ability to stand for more than 30 seconds 5. a MoCA score of less than 26 Exclusion Criteria: 1. unstable or uncontrolled vital signs, including a resting heart rate \>100 or \<40 BPM, a respiratory rate \>20 or \<12 breaths per minute, an SpO2 \< 95%, a central arterial pressure (CAP) \<80 mmHg, and individuals requiring ICP monitoring will also be excluded 2. requiring invasive mechanical ventilation or being deemed unsuitable by the attending physician due to unstable medical conditions 3. the presence of other neurological disorders or unstable vital signs may interfere with the experiment 4. currently hospitalized in the intensive care unit (ICU) 5. Severe visual or hearing impairments, or communication and comprehension difficulties that interfere with study participation Part 2: Inclusion Criteria: 1. Diagnosis of stroke confirmed by brain CT or MRI, with symptom onset more than 7 days prior (subacute or chronic phase) 2. Being 20 years of age or older 3. The ability to stand for more than 30 seconds 4. a MoCA score of less than 26 Exclusion Criteria: 1. unstable or uncontrolled vital signs, including a resting heart rate \>100 or \<40 BPM, a respiratory rate \>20 or \<12 breaths per minute, an SpO2 \< 95%, a central arterial pressure (CAP) \<80 mmHg, and individuals requiring ICP monitoring will also be excluded 2. requiring invasive mechanical ventilation or being deemed unsuitable by the attending physician due to unstable medical conditions 3. the presence of other neurological disorders or unstable vital signs may interfere with the experiment 4. currently hospitalized in the intensive care unit (ICU) 5. Severe visual or hearing impairments, or communication and comprehension difficulties that interfere with study participation Part 3: Inclusion Criteria: 1. Moyamoya disease/syndrome confirmed through CT scan or angiography 2. being in the subacute phase, defined as one week after stroke onset 3. being 20 years of age or older 4. the ability to stand for more than 30 seconds 5. a Montreal Cognitive Assessment (MoCA) score of less than 26. Exclusion Criteria: 1. unstable or uncontrolled vital signs, including a resting heart rate \>100 or \<40 BPM, a respiratory rate \>20 or \<12 breaths per minute, an SpO2 \< 95%, a central arterial pressure (CAP) \<80 mmHg, and individuals requiring ICP monitoring will also be excluded 2. requiring invasive mechanical ventilation or being deemed unsuitable by the attending physician due to unstable medical conditions 3. the presence of other neurological disorders or unstable vital signs that could interfere with the experiment 4. currently hospitalized in the intensive care unit (ICU) 5. Severe visual or hearing impairments, or communication and comprehension difficulties that interfere with study participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Taiwan University

    RECRUITING

    Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.